We reasoned that these modest impacts on tumor progression after eosinophil depletion may be due to the small number of eosinophils in control tumors and that eosinophil infiltration underlies, at least in part, the antitumor response to ATX inhibition. The gene discussed is ENPP2; the disease is neoplasm.